Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. PLEASE COMPLETE ALL RELEVANT BOXES IN BLOCK CAPITAL LETTERS. 1. Name of the issuer: FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC 2. State whether the notification relates to: i. a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (iii) BOTH (i) AND (ii) 3. Name of person discharging managerial responsibilities/director: ANTHONY TOWNSEND 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person: AND MRS C TOWNSEND 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest: AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares: ORDINARY 25p SHARES 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them: NOT STATED 8. State the nature of the transaction: ACQUISITION 9. Number of shares, debentures or financial instruments relating to shares acquired: 1,123 ORDINARY SHARES BY MR A TOWNSEND AND 292 ORDINARY SHARES BY MRS C TOWNSEND. 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage): 0.003% 11. Number of shares, debentures or financial instruments relating to shares disposed: NOT APPLICABLE 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage): NOT APPLICABLE 13. Price per share or value of transaction: 464.00p PER SHARE 14. Date and place of transaction: 5 AUGUST 2009 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage): 18,785 ORDINARY SHARES 0.04% 16. Date issuer informed of transaction: 5 AUGUST 2009 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant: - 18. Period during which or date on which it can be exercised: - 19. Total amount paid (if any) for grant of the option: - 20. Description of shares or debentures involved (class and number): - 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise: - 22. Total number of shares or debentures over which options held following notification: - 23. Any additional information: THE PURCHASE AROSE OUT OF AN EXERCISE OF 1,415 WARRANTS IN THE COMPANY AT AN EXERCISE PRICE OF 464P PER SHARE. 24. Name of contact and telephone number for queries: MARK POPE, COMPANY SECRETARY TEL: 020 3 008 4913 Name and signature of duly authorised officer of issuer responsible for making notification: MARK POPE Date of notification: 7 AUGUST 2009
UK 100

Latest directors dealings